As already mentioned above, first advances towards a therapeutic application of NEAT1 have been made in the context of Herpes simplex infection where virus-induced skin lesions have successfully been treated with gels containing NEAT1 siRNA [93]. The gene discussed is NEAT1; the disease is herpes simplex infectious disease.